Beijing Sinder-vet Technology

Beijing Sinder-vet Technology is a leading Chinese high-tech enterprise specializing in the research, development, and manufacturing of veterinary biological products. As a core subsidiary of the Sinder Group, the company operates advanced GMP-certified facilities in Beijing, including the first production line in China approved for cell suspension culture of highly pathogenic avian influenza vaccines. Their extensive portfolio includes vaccines for poultry, swine, and pets, as well as diagnostic kits and herbal medicines. The company maintains a strong international presence through a strategic joint venture with Sumitomo Corporation and collaborations with global research institutes. Beijing Sinder-vet is recognized for its innovation in genetically engineered vaccines and large-scale bioprocessing, playing a critical role in animal disease prevention and food safety.